Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk.
Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.
215ON201 BIIB033 In Acute Optic Neuritis (AON) (RENEW)
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
Assessment and Imaging of the Cerebrovascular Glycocalyx.
The force awakens: insights into the origin and formation of microglia.
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
The quality of reports of randomized trials in multiple sclerosis: a review.
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
GlaxoSmithKline Product Development Pipeline
Mechanism of action of mitoxantrone.
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
Pages
« first
‹ previous
…
21
22
23
24
25
26
27
28
29
…
next ›
last »